[Clinical test of cefalexin in chronic urinary infections].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002506:Cephalexin / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004754:Enterobacter; D004927:Escherichia coli Infections / Q000188:drug therapy; D005076:Exanthema / Q000139:chemically induced; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011512:Proteus Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002506:Cephalexin
Klinische Prüfung von Cefalexin bei chronischen Harnwegsinfektionen.